X-104250529-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The ENST00000372588.4(ESX1):c.920C>T(p.Pro307Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000916 in 1,092,213 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000372588.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESX1 | NM_153448.4 | c.920C>T | p.Pro307Leu | missense_variant | 4/4 | ENST00000372588.4 | NP_703149.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESX1 | ENST00000372588.4 | c.920C>T | p.Pro307Leu | missense_variant | 4/4 | 1 | NM_153448.4 | ENSP00000361669 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000919 AC: 1AN: 108781Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 31581
GnomAD3 exomes AF: 0.0000244 AC: 2AN: 82105Hom.: 0 AF XY: 0.0000958 AC XY: 2AN XY: 20881
GnomAD4 exome AF: 0.00000915 AC: 9AN: 983432Hom.: 0 Cov.: 32 AF XY: 0.0000130 AC XY: 4AN XY: 308556
GnomAD4 genome AF: 0.00000919 AC: 1AN: 108781Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 31581
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 28, 2022 | The c.920C>T (p.P307L) alteration is located in exon 4 (coding exon 4) of the ESX1 gene. This alteration results from a C to T substitution at nucleotide position 920, causing the proline (P) at amino acid position 307 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at